Reports Q2 revenue $63.74M, consensus $63.16M. “Financial performance in the quarter underscored our commitment to operational efficiency and profitability,” said Kevin Coop, CEO of Definitive Healthcare. “In my first month as CEO, I’m even more confident that this is a business with strong fundamentals. We have a great team with deep domain expertise and a differentiated set of data and technology assets that deliver great value to our customers.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DH:
- Is DH a Buy, Before Earnings?
- Definitive Healthcare announces resignation of CRO Carrie Lazorchak
- Definitive Healthcare cuts FY24 adjusted EPS view to 32c-34c from 36c-38c
- Definitive Healthcare reports preliminary Q2 adjusted EPS 9c, consensus 9c
- Definitive Healthcare price target lowered to $7.50 from $9.50 at Stifel